A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2ep53 antagonist brigimadlin (BI 907828) in patients (pts) with solid tumours Meeting Abstract
| Authors: | Schoeffski, P.; Lorusso, P.; Yamamoto, N.; Lugowska, I.; Garcia, V. M.; Lauer, U.; Hu, C.; Jayadeva, G.; Lahmar, M.; Gounder, M. |
| Abstract Title: | A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2ep53 antagonist brigimadlin (BI 907828) in patients (pts) with solid tumours |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S472 |
| Language: | English |
| ACCESSION: | WOS:001087480201015 |
| DOI: | 10.1016/j.annonc.2023.09.1859 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 673P -- Source: Wos |
